Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Characterization of Patients with Glanzmann Thrombasthenia and Identification of 17 Novel Mutations

Kirstin Sandrock-Lang, PhD, Johannes Oldenburg, MD PhD, Verena Wiegering, MD, Susan Halimeh, MD, Sentot Santoso, Karin Kurnik, Lars Fischer, Dimitrios Tsakiris, MD, Michael Sigl-Kraetzig, Brigit Brand, MD, Katharina Kraetzer, Niklas Deeg, Eileen Busse, Zieger Barbara

Blood (2014) 124 (21): 1460.

https://doi.org/10.1182/blood.V124.21.1460.1460

Published: 2014

Journal Articles

Systemic Relapses In Primary CNS Lymphoma (PCNSL) - Unexpected Clonal Diversity

Lars Fischer, Michael Hummel, Prof., Agnieszka Korfel, Dido Lenze, Kristoph Jahnke, Philipp Kiewe, Michael Weller, Prof., Eckhard Thiel, Prof.

Blood (2010) 116 (21): 3125.

https://doi.org/10.1182/blood.V116.21.3125.3125

Published: 2010

Journal Articles

Peripheral Blood Stem Cell Mobilization After Bendamustine Containing Chemotherapy in Indolent Lymphomas Is Possible. Results From the Phase III Study of B-R Vs. CHOP-R (NHL 1-2003 trial) of the StiL (Study group indolent Lymphomas, Germany).

Christoph Alexander Burchardt, Wolfram Brugger, Georg Maschmeyer, Dorothea Kofahl-Krause, Lars Fischer, Fritz Roller, Juergen Barth, Mathias J Rummel

Blood (2009) 114 (22): 2679.

https://doi.org/10.1182/blood.V114.22.2679.2679

Published: 2009

Journal Articles

MicroRNAs Are Differentially Expressed in Primary Central Nervous (CNS) and Nodal Diffuse Large B-Cell Lymphomas.

Lars Fischer, Michael Hummel, Agnieszka Korfel, Dido Lenze, Korinna Jöhrens, Eckhard Thiel, MD, PhD

Blood (2009) 114 (22): 2929.

https://doi.org/10.1182/blood.V114.22.2929.2929

Published: 2009

Journal Articles

Meningeal Dissemination (MD) in Primary CNS Lymphoma (PCNSL): Multimodal Diagnosis, Presentation and Outcome in a Large Monocenter Patient Cohort

Philipp Kiewe, Agnieszka Korfel, Lars Fischer, Peter Martus, Eckhard Thiel

Blood (2008) 112 (11): 5300.

https://doi.org/10.1182/blood.V112.11.5300.5300

Published: 2008

Journal Articles

High Expression of IL-15 Correlates with Disease Recurrence of Adult B-Lineage Acute Lymphoblastic Leukemia

Shuling Wu, MD, Lars Fischer, Thomas Burmeister, Stefan Schwartz, Michael Notter, Nicola Gökbuget, Dieter Hoelzer, Wolf-Karsten Hofmann, Eckhard Thiel

Blood (2008) 112 (11): 4863.

https://doi.org/10.1182/blood.V112.11.4863.4863

Published: 2008

Journal Articles

CXCL12 and CXCL13 Levels in Cerebrospinal Fluid (CSF) of Patients with CNS Lymphoma.

Lars Fischer, MD, Philipp Kiewe, MD, Sebastian Pfeiffer, MD, Hüsniye Cakiroglu, Eckhard Thiel, MD

Blood (2007) 110 (11): 1576.

https://doi.org/10.1182/blood.V110.11.1576.1576

Published: 2007

Journal Articles

Primary Central Nervous System Lymphoma (PCNSL): Intent-to-Treat Analysis of Monocenter Long-Term Experience.

Agnieszka Korfel, MD, Philipp Kiewe, MD, Lars Fischer, MD, Peter Mertus, PhD, Eckhard Thiel, PhD

Blood (2007) 110 (11): 1365.

https://doi.org/10.1182/blood.V110.11.1365.1365

Published: 2007

Journal Articles

Alemtuzumab but Not ATG Decreases Natural Killer (NK) Cell Activity towards Tumor Targets in the Early Phase after Allogeneic Stem Cell Transplantation.

Olaf Penack, MD, Lars Fischer, MD, Andrea Stroux, Chiara Gentilini, MD, Axel Nogai, MD, Arne Muessig, MD, Susanne Ganepola, MD, Eckhard Thiel, MD, Lutz Uharek, MD

Blood (2006) 108 (11): 2869.

https://doi.org/10.1182/blood.V108.11.2869.2869

Published: 2006

Journal Articles

High Anti-Tumor Activity of Natural Killer Cells after Non-Myeloablative Conditioning and Allogeneic Stem Cell Transplantation.

Lars Fischer, MD, Olaf Penack, MD, Andrea Stroux, Chiara Gentilini, MD, Eckhard Thiel, Lutz Uharek

Blood (2006) 108 (11): 5146.

https://doi.org/10.1182/blood.V108.11.5146.5146

Published: 2006

Journal Articles

Quantification and Characterization of Peripheral Blood Natural Killer (NK) Cells Mediating Rituximab and Alemtuzumab Dependent Cytotoxicity.

Olaf Penack, MD, Lars Fischer, MD, Chiara Gentilini, MD, Anne M. Asemissen, MD, Carmen Scheibenbogen, MD, Eckhard Thiel, MD, Lutz Uharek, MD

Blood (2005) 106 (11): 2808.

https://doi.org/10.1182/blood.V106.11.2808.2808

Published: 2005

Journal Articles

Analysis of Factors Influencing Natural Killer (NK) Cell Activity during the Early Phase after Allogeneic Stem Cell Transplantation (SCT).

Lars Fischer, MD, Olaf Penack, MD, Chiara Gentilini, MD, Eckhard Thiel, MD, Uharek Lutz, MD

Blood (2005) 106 (11): 2192.

https://doi.org/10.1182/blood.V106.11.2192.2192

Published: 2005

Journal Articles

Cyclin D1 Expression in Mantle Cell Lymphoma Is Accompanied by Downregulation of Cyclin D3 and Is Not Related to the Proliferative Activity

M. Michaela Ott, Jirina Bartkova, Jiri Bartek, Alexander Dürr, Lars Fischer, German Ott, Hans Konrad Müller-Hermelink, Hans Kreipe

Blood (1997) 90 (8): 3154–3159.

https://doi.org/10.1182/blood.V90.8.3154

Published: 1997

NARROW

Characterization of Patients with Glanzmann Thrombasthenia and Identification of 17 Novel Mutations

Systemic Relapses In Primary CNS Lymphoma (PCNSL) - Unexpected Clonal Diversity

Peripheral Blood Stem Cell Mobilization After Bendamustine Containing Chemotherapy in Indolent Lymphomas Is Possible. Results From the Phase III Study of B-R Vs. CHOP-R (NHL 1-2003 trial) of the StiL (Study group indolent Lymphomas, Germany).

MicroRNAs Are Differentially Expressed in Primary Central Nervous (CNS) and Nodal Diffuse Large B-Cell Lymphomas.

Meningeal Dissemination (MD) in Primary CNS Lymphoma (PCNSL): Multimodal Diagnosis, Presentation and Outcome in a Large Monocenter Patient Cohort

High Expression of IL-15 Correlates with Disease Recurrence of Adult B-Lineage Acute Lymphoblastic Leukemia

CXCL12 and CXCL13 Levels in Cerebrospinal Fluid (CSF) of Patients with CNS Lymphoma.

Primary Central Nervous System Lymphoma (PCNSL): Intent-to-Treat Analysis of Monocenter Long-Term Experience.

Alemtuzumab but Not ATG Decreases Natural Killer (NK) Cell Activity towards Tumor Targets in the Early Phase after Allogeneic Stem Cell Transplantation.

High Anti-Tumor Activity of Natural Killer Cells after Non-Myeloablative Conditioning and Allogeneic Stem Cell Transplantation.

Quantification and Characterization of Peripheral Blood Natural Killer (NK) Cells Mediating Rituximab and Alemtuzumab Dependent Cytotoxicity.

Analysis of Factors Influencing Natural Killer (NK) Cell Activity during the Early Phase after Allogeneic Stem Cell Transplantation (SCT).

Cyclin D1 Expression in Mantle Cell Lymphoma Is Accompanied by Downregulation of Cyclin D3 and Is Not Related to the Proliferative Activity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only